The EMA's CHMP has finalised a review of recently published information on the cardiovascular (CV) safety of NSAIDs, News item 29 December 2012 Pages: 2 - 2
Elderly Danes prescribed less high-dose dabigatran after warning News item 29 December 2012 Pages: 3 - 3
Keep eye drops & nasal sprays out of reach of children, warns FDA News item 29 December 2012 Pages: 3 - 3
Hypotonic saline solution (0.18% saline/4% glucose) must not be used in children aged ≤16 years News item 29 December 2012 Pages: 3 - 3
Levothyroxine Alapis: risk of med errors tips benefit-risk balance News item 29 December 2012 Pages: 4 - 4
The EMA has started an infringement procedure against Roche Registration Ltd., Media release 29 December 2012 Pages: 5 - 5
In June 2012, the EMA's CHMP recommended that the marketing authorisation granted to Loraxin [loratadine] in Finland should not be recognised News item 29 December 2012 Pages: 5 - 5
Control measures to minimise the abuse psuedoephedrine- or ephedrine-containing News item 29 December 2012 Pages: 5 - 5
Amoxicillin/clavulanic acid/nitrofurantoin/piperacillin/tazobactam Case report 29 December 2012 Pages: 9 - 9